Cancer cells, especially those in ALL, often rely on external sources of asparagine due to their inability to produce sufficient amounts internally. Asparaginase depletes the levels of asparagine in the bloodstream, starving the cancer cells and leading to their death. Normal cells, in contrast, can synthesize asparagine and are less affected by this treatment.
